CrossrefInfokarte
Long-term outcomes and immune reconstitution after tisagenlecleucel in relapsed or refractory large B-cell lymphoma: a single-institution retrospective study in Japan with over 3 years follow-up
Journal of Clinical and Experimental Hematopathology · 2026
DOI: 10.3960/jslrt.26040 ↗Abstract
Kein Abstract verfügbar.
EUVIMED